Pagaya Technologies Ltd.
PGY Nasdaq Finance Services Financials FY2021βFY2025
What Pagaya Technologies Ltd. does
No business description yet.
- Legal name
- Pagaya Technologies Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 2, 2026
- Accession Β· CIK
- 0001883085-26-000018
0001883085
Revenue and margins
Pagaya Technologies Ltd. had $1.3B of revenue in fiscal 2025, up 26.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $225M in fiscal 2025, 17.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Pagaya Technologies Ltd. returned β to shareholders in fiscal 2025. The diluted share count rose 17.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Pagaya Technologies Ltd. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $191M | $310M | $186M | $210M | $235M |
| Debt incl. finance leases | β | $61.8M | $37.7M | $321M | β |
| Net debt / EBITDA | β | β | β | 1.2x | β |
| Debt / equity | β | 0.1x | 0.1x | 1.0x | β |
| Current ratio | β | 3.3x | 4.0x | 1.8x | β |
| Quick ratio | β | 3.3x | 4.0x | 1.8x | β |
| Total assets | β | $1.0B | $1.2B | $1.3B | $1.5B |
| Total liabilities | β | $280M | $468M | $775M | $960M |
| Shareholders' equity | $177M | $554M | $560M | $326M | $480M |
| Net debt (β = net cash) | β | β$248M | β$149M | $111M | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 4 / 9 | 4 / 9 | 6 / 7 |
| Accruals ratio | β | β25.1% | β9.5% | β35.9% | β11.1% |
| Altman Z'' | β | 1.00 | 0.90 | β0.80 | β |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $475M | $749M | $812M | $1.0B | $1.3B |
| Gross profit | $242M | $298M | $303M | $435M | $552M |
| Research and development | $66.2M | $151M | $74.4M | $76.6M | $75.2M |
| Operating income | β$5.8M | β$252M | β$24.4M | $66.8M | $264M |
| Pretax income | β$61.6M | β$276M | β$181M | β$421M | $51.6M |
| Income tax | $7.9M | $16.4M | $15.6M | $24.6M | β$19.7M |
| Net income | β$91.2M | β$302M | β$128M | β$401M | $81.4M |
| Net income to common | β$134M | β$315M | β$128M | β$401M | $77.3M |
| Diluted EPS | β$8.25 | β$8.22 | β$2.14 | β$5.66 | $0.93 |
| Diluted shares | 0.02B | 0.04B | 0.06B | 0.07B | 0.08B |
| Cash flow | |||||
| Cash from operations | $49.8M | β$40.0M | β$21.7M | $47.8M | $239M |
| Capital expenditure | $6.6M | $22.4M | $20.2M | $17.7M | $13.9M |
| Free cash flow | $43.2M | β$62.4M | β$41.8M | $30.0M | $225M |
| Depreciation and amortization | $0.8M | $6.3M | $19.1M | $28.8M | $30.1M |
| Stock-based compensation | $67.8M | $242M | $71.1M | $61.5M | $54.1M |
| Acquisitions | β | β | β | $9.1M | β$0.2M |
| Balance sheet | |||||
| Cash and short-term investments | $191M | $310M | $186M | $210M | $235M |
| Total debt | β | $61.8M | $37.7M | $321M | β |
| Current assets | β | $420M | $303M | $351M | β |
| Current liabilities | β | $128M | $74.9M | $195M | β |
| Property and equipment, net | β | $31.7M | $41.6M | $38.0M | $30.2M |
| Goodwill | β | $0.0M | $10.9M | $23.1M | $22.9M |
| Intangible assets | β | $0.0M | $2.6M | $12.8M | $7.7M |
| Total assets | β | $1.0B | $1.2B | $1.3B | $1.5B |
| Total liabilities | β | $280M | $468M | $775M | $960M |
| Shareholders' equity | $177M | $554M | $560M | $326M | $480M |
| Margins | |||||
| Gross margin | 51.0% | 39.8% | 37.3% | 42.1% | 42.4% |
| Operating margin | β1.2% | β33.6% | β3.0% | 6.5% | 20.3% |
| EBITDA margin | β1.1% | β32.7% | β0.6% | 9.3% | 22.6% |
| Net margin | β19.2% | β40.4% | β15.8% | β38.9% | 6.3% |
| FCF margin | 9.1% | β8.3% | β5.2% | 2.9% | 17.3% |
| Returns | |||||
| Return on capital | β | β65.0% | β4.7% | 12.1% | β |
| Return on capital employed | β | β27.4% | β2.2% | 6.1% | β |
| Return on equity | β51.4% | β82.7% | β23.1% | β90.6% | 20.2% |
| Return on assets | β | β28.9% | β11.4% | β32.1% | 5.7% |
| Return on tangible equity | β75.7% | β56.8% | β23.5% | β138.1% | 17.2% |
| Growth | |||||
| Revenue growth | β | 57.8% | 8.4% | 27.1% | 26.1% |
| FCF growth | β | β244.5% | β | β | 648.7% |
| Share count change | β | 135.0% | 56.9% | 18.1% | 17.2% |
| Financial health | |||||
| Net debt / EBITDA | β | β | β | 1.2x | β |
| Debt / equity | β | 0.1x | 0.1x | 1.0x | β |
| Current ratio | β | 3.3x | 4.0x | 1.8x | β |
| Quick ratio | β | 3.3x | 4.0x | 1.8x | β |
| Capital allocation | |||||
| Capex / revenue | 1.4% | 3.0% | 2.5% | 1.7% | 1.1% |
| Stock comp / revenue | 14.3% | 32.3% | 8.8% | 6.0% | 4.2% |
| Quality scores | |||||
| Piotroski F-score | β | β | 4.0 | 4.0 | 6.0 |
| Altman Z'' | β | 1.0 | 0.9 | β0.8 | β |
| Accruals ratio | β | β25.1% | β9.5% | β35.9% | β11.1% |
Source: SEC EDGAR XBRL filings (CIK 0001883085). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.